Costs of a Public-Private Partnership for TB Control in Nepal
Author Information
Author(s): Karki Deepak K, Mirzoev Tolib N, Green Andrew T, Newell James N, Baral Sushil C
Primary Institution: Nuffield Centre for International Health and Development, University of Leeds
Hypothesis
The study aims to evaluate the feasibility, effectiveness, and costs of public-private partnerships for TB control in an urban setting in Nepal.
Conclusion
The PPP for treating TB patients resulted in low additional costs while significantly increasing case notification rates and maintaining high success rates.
Supporting Evidence
- The average cost for treating a TB patient under the PPP scheme was US$89.60.
- Start-up costs per patient represented 12% of the total budget.
- Half of the recurrent costs were incurred by patients and their escorts.
- Female patients tended to spend more on treatment.
Takeaway
This study shows that working together with private doctors to treat TB can help more people get better without costing too much money.
Methodology
The study used semi-structured interviews to collect data on costs incurred by health facilities, patients, and their escorts.
Limitations
The study did not include research project costs as part of the costs for treating a TB patient.
Participant Demographics
Of the 50 patients interviewed, 27 were male and 23 were female.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website